MVA Investors, LLC - Feb 9, 2023 Form 4 Insider Report for Tyra Biosciences, Inc. (TYRA)

Role
10%+ Owner
Signature
By: Aaron I. Davis, Chief Executive Officer, MVA Investors, LLC
Stock symbol
TYRA
Transactions as of
Feb 9, 2023
Transactions value $
-$3,498,611
Form type
4
Date filed
2/13/2023, 08:39 PM
Next filing
May 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TYRA Common Stock Sale -$2.62M -200K -69.42% $13.10 88.1K Feb 9, 2023 Direct F1
transaction TYRA Common Stock Sale -$879K -65.6K -74.43% $13.40 22.5K Feb 10, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are held directly by MVA Investors, LLC ("MVA Investors"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) MVA Investors, (ii) Boxer Capital, LLC, (iii) Boxer Asset Management Inc., (iv) Aaron I. Davis, (v) Joseph C. Lewis and (vi) Siddarth Subramony (collectively, the "Boxer Group"), and indirectly by Mr. Davis who is a member of and has voting and dispositive power over securities held by MVA Investors. Each member of the Boxer Group other than MVA Investors disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.